Login to Your Account

Antisoma Enters Broad Deal With Roche, Receives $43M Up Front

By Nuala Moran

Tuesday, November 19, 2002
Antisoma plc entered a deal with F. Hoffmann-La Roche Ltd. that has a headline value of US$500 million, including up-front payments of $43 million, more than Antisoma's market capitalization of £26.4 million when the markets closed Friday. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription